HUVEXEL Co.,Ltd. (XKON:A212310) agreed to acquire 45.27 stake in Bioriginkorea Co., Ltd. from DTNI-Jeonnam Creative Economy Innovation Fund managed by Dt&Investment Co.,Ltd. for KRW 2.268 billion on July 29, 2021. The consideration will be through the issuance of new shares of Huvexel on the closing date of the transaction on August 13, 2021. For the year 2020, Bioriginkorea reported total assets of KRW 3.49 billion, total debt of KRW 1.1 billion total equity of KRW 2.385 billion, sales of KRW 259 million, Net Loss of KRW 208 million.